NICE plots takeover of England’s Cancer Drugs Fund

Emily Wasserman

England's has been dealing with budget overruns and backlash from drugmakers and patients unhappy with the 's decision to ax certain meds from its list. Now, the country's cost watchdogs are planning to take the reins and give the a much-needed makeover.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS